List of insiders holdings for Intra-Cellular Therapies Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| ALAFI CAPITAL CO LLC 10% Owner | 2019-09-30 17:11:54 | 5,796,504 0 | 5,796,504 | Form 13D |
| Alafi Christopher D Director | 2021-05-28 18:00:27 | 346,795 5,342,523 | 5,689,318 | Form 4 |
| ALAFI MOSHE 10% Owner | 2017-10-03 18:11:46 | 0 3,953,270 | 3,953,270 | Form 4 |
| Sosland Morton I. 10% Owner | 2018-02-01 16:01:38 | 2,638,389 0 | 2,638,389 | Form 13G |
| Mates Sharon Chairman and CEO | 2024-08-30 18:01:46 | 1,310,119 0 | 1,310,119 | Form 4 |
| Fienberg Allen A. VP of Business Development | 2015-09-11 16:53:46 | 295,000 197,823 | 492,823 | Form 4 |
| Davis Robert E SVP, Chief Scientific Officer | 2019-01-08 21:16:12 | 174,531 0 | 174,531 | Form 4 |
| Vanover Kimberly E. SVP, Early Stage Clinical Dev. | 2019-01-08 21:19:21 | 166,934 0 | 166,934 | Form 4 |
| RIGGS RORY B Director | 2024-10-15 18:00:03 | 131,297 0 | 131,297 | Form 4 |
| Wennogle Lawrence P. Vice President, Drug Discovery | 2015-06-09 17:04:04 | 126,500 0 | 126,500 | Form 4 |
| LERNER RICHARD A Director | 2021-10-04 17:43:21 | 11,430 96,663 | 108,093 | Form 4 |
| Satlin Andrew EVP and Chief Medical Officer | 2020-02-20 19:27:13 | 60,171 0 | 60,171 | Form 4 |
| Narula Sanjeev Executive Vice President & CFO | 2024-08-14 18:01:19 | 52,297 0 | 52,297 | Form 4 |
| MARCUS JOEL S Director | 2024-06-25 18:05:06 | 41,229 10,000 | 51,229 | Form 4 |
| Sanchez Juan F. VP, Corp. Communications & IR | 2015-01-06 17:19:24 | 30,050 0 | 30,050 | Form 4 |
| Neumann Mark EVP, Chief Commercial Officer | 2024-08-20 18:03:54 | 29,700 0 | 29,700 | Form 4 |
| Durgam Suresh K. EVP, Chief Medical Officer | 2024-03-11 20:31:31 | 27,148 0 | 27,148 | Form 4 |
| Rawlins Michael Director | 2022-06-13 17:06:12 | 16,757 0 | 16,757 | Form 4 |
| VAN NOSTRAND ROBERT L Director | 2024-07-02 20:00:32 | 11,340 0 | 11,340 | Form 4 |
| Hineline Lawrence J. SVP of Finance, CFO | 2024-03-11 20:33:11 | 10,121 0 | 10,121 | Form 4 |
| Halstead Michael EVP and General Counsel | 2024-03-11 20:32:14 | 7,345 0 | 7,345 | Form 4 |
| Salas Eduardo Rene Director | 2024-06-25 18:05:20 | 1,567 0 | 1,567 | Form 4 |
| MASRI SAMIR NAJI CEO, CFO, Pres & Secretary | 2013-04-09 14:25:13 | 0 0 | 0 | Form 3 |
| NLBDIT 2010 SERVICES LLC NATHAN LOW 2008 IRREVOCABLE TRUST LOW NATHAN A former 10% owner | 2014-02-14 21:33:56 | 0 0 | 0 | Form 5 |